These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 16211882)
21. [Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier Integrity in Lung Cancer Patients with Leptomeningeal Metastasis]. Lin Y; Yu T; Li H; Yin Z; Guo A Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):567-576. PubMed ID: 34120432 [TBL] [Abstract][Full Text] [Related]
22. Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancer. Bach F; Bach FW; Pedersen AG; Larsen PM; Dombernowsky P Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1703-9. PubMed ID: 2632253 [TBL] [Abstract][Full Text] [Related]
23. Meningeal carcinomatosis in lung cancer. Case 1. Carcinomatous leptomeningeal metastases. Wong ET; Joseph JT J Clin Oncol; 2000 Aug; 18(15):2926-7. PubMed ID: 10920141 [No Abstract] [Full Text] [Related]
25. EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors. Milojkovic Kerklaan B; Pluim D; Bol M; Hofland I; Westerga J; van Tinteren H; Beijnen JH; Boogerd W; Schellens JH; Brandsma D Neuro Oncol; 2016 Jun; 18(6):855-62. PubMed ID: 26566655 [TBL] [Abstract][Full Text] [Related]
26. Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors. Gajjar A; Fouladi M; Walter AW; Thompson SJ; Reardon DA; Merchant TE; Jenkins JJ; Liu A; Boyett JM; Kun LE; Heideman RL J Clin Oncol; 1999 Jun; 17(6):1825-8. PubMed ID: 10561221 [TBL] [Abstract][Full Text] [Related]
27. Leptomeningeal Metastases in Non-small Cell Lung Cancer: Optimal Systemic Management in NSCLC With and Without Driver Mutations. Alexander M; Lin E; Cheng H Curr Treat Options Oncol; 2020 Jul; 21(9):72. PubMed ID: 32725549 [TBL] [Abstract][Full Text] [Related]
28. [Leptomeningeal metastases from solid tumors]. Le Rhun E; Zairi F; Boulanger T; Taillibert S Rev Prat; 2014 Jan; 64(1):15-8. PubMed ID: 24649536 [TBL] [Abstract][Full Text] [Related]
29. Leptomeningeal metastases: a review of evaluation and treatment. Chamberlain MC J Neurooncol; 1998 May; 37(3):271-84. PubMed ID: 9524085 [TBL] [Abstract][Full Text] [Related]
31. Leptomeningeal carcinomatosis and cranial nerve palsy as presenting symptoms of a clinically inapparent gallbladder carcinoma. Gaumann A; Marx J; Bohl J; Kommoss F; Köhler H; Tews DS Pathol Res Pract; 1999; 195(7):495-9. PubMed ID: 10448666 [TBL] [Abstract][Full Text] [Related]
32. Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer. Stemmler HJ; Schmitt M; Harbeck N; Willems A; Bernhard H; Lässig D; Schoenberg S; Heinemann V Oncol Rep; 2006 May; 15(5):1373-7. PubMed ID: 16596213 [TBL] [Abstract][Full Text] [Related]
33. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report. Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096 [TBL] [Abstract][Full Text] [Related]
34. Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions. Wilcox JA; Chukwueke UN; Ahn MJ; Aizer AA; Bale TA; Brandsma D; Brastianos PK; Chang S; Daras M; Forsyth P; Garzia L; Glantz M; Oliva ICG; Kumthekar P; Le Rhun E; Nagpal S; O'Brien B; Pentsova E; Lee EQ; Remsik J; Rudà R; Smalley I; Taylor MD; Weller M; Wefel J; Yang JT; Young RJ; Wen PY; Boire AA Neuro Oncol; 2024 Oct; 26(10):1781-1804. PubMed ID: 38902944 [TBL] [Abstract][Full Text] [Related]
35. Simultaneous primary cancer occurrence of melanoma and pulmonary adenocarcinoma in leptomeningeal metastases: a case report. Stoppek AK; Kebir S; Junker A; Keyvani K; Zülow S; Lazaridis L; Schmidt T; Pierscianek D; Stuschke M; Sure U; Kleinschnitz C; Scheffler B; Zimmer L; Glas M BMC Cancer; 2019 Oct; 19(1):995. PubMed ID: 31646997 [TBL] [Abstract][Full Text] [Related]
36. Meningeal carcinomatosis from small cell carcinoma of the lung. Consequence of improved survival. Aisner J; Aisner SC; Ostrow S; Govindan S; Mummert K; Wiernik P Acta Cytol; 1979; 23(4):292-9. PubMed ID: 231364 [TBL] [Abstract][Full Text] [Related]
38. Carbohydrate antigen 19-9 in cerebrospinal fluid and within malignant cells in a case of leptomeningeal carcinomatosis. Sato Y; Ohta Y; Kaji M; Oizumi K; Kaji M J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):402-3. PubMed ID: 9728963 [No Abstract] [Full Text] [Related]
40. Leptomeningeal metastases in pediatrics: magnetic resonance image manifestations and correlation with cerebral spinal fluid cytology. Porto L; Kieslich M; Bartels M; Schwabe D; Zanella FE; Du Mesnil R Pediatr Int; 2010 Aug; 52(4):541-6. PubMed ID: 20534022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]